Pluri Inc (PLUR) - News Archive

In a significant development aimed at enhancing Ukraine’s resilience against radiation emergencies, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a pioneering biotechnology firm, has entered into an exclusive collaboration ag...

Pluri Inc. Secures $3.5 Million Investment, Paving the Way for Future GrowthPluri Inc. a leading biotechnology company based in Haifa, Israel, has successfully completed a private placement investment of $3.5 million fr...

IntroductionOn January 23, 2025, Haifa, Israel, witnessed a remarkable financial maneuver in the biotechnology sector with Pluri Inc. (Nasdaq: PLUR; TASE:PLUR) announcing a strategic investment of $6.5 million, primaril...

In an ever-evolving landscape of the life sciences sector, innovation and scalability are paramount, and few companies are embodying these ideals more effectively than PluriCDMO. Recently shortlisted for the prestigious...

In an age marked by heightened global tensions, especially regarding nuclear threats, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a biotechnology company based in Haifa, Israel, has placed itself at the forefront of a criti...

Pluri, a leading player in the agriculture and food production industry, has recently unveiled a groundbreaking initiative aimed at enhancing the global supply of sustainable vegetables. The company has inked a $1 milli...

HAIFA, Israel, June 18, 2024 - Biotechnology company Pluri Inc. has recently announced strategic investments in its subsidiary, Ever After Foods Ltd. This subsidiary offers a cutting-edge technology platform that aims t...

U.S. National Institutes of Health Continues Funding for Pluri Inc. s PLX-R18 Acute Radiation Syndrome ContractHAIFA, Israel, June 06, 2024 - Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a leading biotechnology company speci...

Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial ScaleHAIFA, Israel - In a groundbreaking partnership, leading biotechnology comp...

Pluri Inc., a renowned biotechnology powerhouse, globally esteemed for transforming cells into viable treatment solutions, aspires to revolutionize the cancer treatment sector once again. On May 02, 2024, the company un...

Haifa-based biotechnology company, Pluri Inc., has recently made a significant announcement regarding its common shares. Known for its groundbreaking advancements in cell transformation, Pluri Inc. has revealed plans fo...

Pluri Inc, a leading biotechnology company based in Haifa, Israel, has responded to the price volatility challenge highlighted in the International Coffee Organizations (ICO) 2024 Market Report. The report identifies er...

In a groundbreaking development for the treatment of Idiopathic Pulmonary Fibrosis (IPF), cell therapy pioneer Remedy Cell has teamed up with PluriCDMO to manufacture their highly anticipated product candidate, RC-0315....

HAIFA, Israel, Feb. 28, 2024 - Pluri Inc., a leading biotechnology company, has recently shared an update from its CEO and President, Yaky Yanay, highlighting the company s achievements and outlining its goals for the y...

Step into the Future: Pluri Inc. Introduces Cell-Based Coffee to Combat the Global Coffee CrisisHAIFA, Israel, Jan. 23, 2024 - Pluri Inc., a prominent biotech company dedicated to promoting global well-being and sustain...

Pluri and Bar-Ilan University Collaborate to Develop Groundbreaking Treatment for Cocaine AddictionHAIFA, Israel - In an exciting development for the biomedical field, Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR), a renowned...